Compare VRE & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRE | AORT |
|---|---|---|
| Founded | 1949 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1995 | 1996 |
| Metric | VRE | AORT |
|---|---|---|
| Price | $18.91 | $36.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $19.50 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 1.2M | 367.6K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 420.00 | 165.62 |
| EPS | ★ 0.80 | 0.21 |
| Revenue | $288,434,000.00 | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | $2.87 | $11.17 |
| P/E Ratio | ★ $23.63 | $167.55 |
| Revenue Growth | 6.40 | ★ 18.01 |
| 52 Week Low | $13.69 | $22.22 |
| 52 Week High | $19.03 | $48.25 |
| Indicator | VRE | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 69.67 | 48.69 |
| Support Level | $18.85 | $34.60 |
| Resistance Level | $18.97 | $38.42 |
| Average True Range (ATR) | 0.05 | 1.43 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 35.50 | 72.41 |
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.